biopharmaceutical - International Biopharmaceutical Industry

news

Biopharma Takes on Deadly Brain Cancer After Decades of Failure

Emboldened by technological advances and a deeper knowledge of glioblastoma, Merck, Kazia Therapeutics, CorriXR Therapeutics and others are targeting the often-fatal...

2 December 2024 news biopharma | biopharmaceutical

Continue Reading →

news

Abingworth ‘Will Launch $1.5bn Fund for Co-developed Drugs’

Venture capital group Abingworth is reportedly trying to raise up to $1.5 billion in investment funding to support biopharma companies' clinical development programm...

2 December 2024 news Abingworth | biopharma

Continue Reading →

news

Sanofi Opens $590M Modular Vaccine, Biologics Plant in Singapore

Two months after Sanofi completed construction in France of its innovative Modulus vaccine and biologics plant—which can be reconfigured within days during a pan...

2 December 2024 news biologics | biopharma

Continue Reading →

news

M&A anxiety, Roche’s comeback plan and Vir’s omicron moment

The second day of the J.P. Morgan Healthcare Conference, much like the first, didn't include the type of market-moving acquisitions or announcements that might break ...

14 January 2022 news anxiety | biopharmaceutical

Continue Reading →

news

AstraZeneca builds case for long-acting COVID-19 drug, but is it too late?

In some ways, AstraZeneca's COVID-19 response has been as good as any in the biopharmaceutical industry. The British drugmaker licensed and developed an effective CO...

15 October 2021 news AstraZeneca | AZD7442

Continue Reading →

news

Avacta appoints Dr Fiona McLaughlin as Chief Scientific Officer of its Therapeutics Division

Avacta Group plc (AIM: AVCT), a clinical-stage biopharmaceutical company developing innovative cancer therapies and powerful diagnostics based on its proprietary Affi...

2 September 2021 news Avacta | Avacta Group plc

Continue Reading →

news

Trade Idea: Biopharmaceutical Endocyte Hits 4-Year High on Earnings

With a market capitalization of just under $800 million, Indiana-based biopharmaceutical firm Endocyte (ECYT) Trade repo...

11 May 2018 news 4 | biopharmaceutical

Continue Reading →

news

Biopharmaceuticals Market Strongly guided by Companies like ABBVIE, AMGEN, BRISTOL

The market is expected to register a CAGR of 8.5% during the forecast period 2018 to 2023. North America dominates the market due to the increasing technological adva...

11 May 2018 news ABBVIE | biopharmaceutical

Continue Reading →

news

Putting the Technicals Into Perspective For Sino Biopharmaceutical ADR (SBHMY)

Investors have placed Sino Biopharmaceutical ADR (SBHMY) shares on watch as the Aroon Up indicator has moved above 70, indicating that there is strong upward momentum...

11 May 2018 news ADR | biopharmaceutical

Continue Reading →